Under construction – not a live service
Sign in

What researchers published on Ankylosing spondylitis

959 papers, newest first.

Showing 20 of 959

  • Not labelled yetFactors Associated With Early Axial Spondyloarthritis in a Multiethnic Asian Cohort in Singapore.International journal of rheumatic diseases
  • Not labelled yetIllness perceptions among adults aged 18-44 years with ankylosing spondylitis: A qualitative study informed by the common-sense model of self-regulation.PloS one
  • Not labelled yetWTAP regulates PTEN through m6A methylation to modulate the inflammatory response in CD4+ T cells from patients with ankylosing spondylitis.Clinical and experimental rheumatology
  • Not labelled yetDeep Immunophenotyping Unravels the Double Negative T cells and PD-1-Mediated Inflammatory Exhaustion in Ankylosing Spondylitis.Phenomics (Cham, Switzerland)
  • Not labelled yetClinical significance of decreased serum interleukin-38 concentration in patients with ankylosing spondylitis.Clinica chimica acta; international journal of clinical chemistry
  • Not labelled yetPathological Ossification of Spinal Ligament-Derived Fibroblasts in an Inflammatory Micro-Environment via Activation of the ECM/ITGA5/FAK/AKT Pathway in Ankylosing Spondylitis.Cell proliferation
  • Not labelled yetKey genes in ferroptosis and oxidative stress pathways associated with ankylosing spondylitis.Annals of medicine
  • Not labelled yetReliability and feasibility of the ankylosing spondylitis performance index (ASPI) in routine clinical care for patients with axial spondyloarthritis.Clinical rheumatology
  • Not labelled yetShort echo time first-echo images of T2* mapping for detecting structural sacroiliac joint lesions in axial spondyloarthritis: a CT-referenced study.Frontiers in immunology
  • Not labelled yetRevised ASAS-SPARTAN 2025 classification criteria and treatment outcomes in axial spondyloarthritis: evidence from a large observational registry.RMD open
  • Case reportCase Report: Sacrococcygeal teratoma with malignant transformation into mixed adenocarcinoma and squamous cell carcinoma following TNF-α inhibitor therapy for ankylosing spondylitis.Frontiers in oncology
  • Not labelled yetDifficult-to-manage axial spondyloarthritis-an analysis in five Nordic registries inspired by recent ASAS definitions.Rheumatology (Oxford, England)
  • Not labelled yetClinical phenotype, disease burden and inter-regional heterogeneity of axial spondyloarthritis in 1112 patients across 15 Arab countries: the PROSPA study.RMD open
  • ReviewApplicability of metabolomics in axial spondyloarthritis: a scoping review.Advances in rheumatology (London, England)
  • Not labelled yetArtificial intelligence-based decision support for axial spondyloarthritis integrating inflammatory and structural MRI information.Frontiers in immunology
  • Not labelled yet[Underestimated Risk in Ankylosing Spondylitis: Iatrogenic Thoracic Spine Fracture During Revision Hip Arthroplasty With Fatal Outcome].Zeitschrift fur Orthopadie und Unfallchirurgie
  • Case reportTurner syndrome complicating osteogenesis imperfecta, thyroiditis and ankylosing spondylitis: a case report.Journal of medical case reports
  • Not labelled yetSarcopenia in Patients with Axial Spondyloarthritis: Associations with TNF Inhibitor Therapy and Exploratory Ultrasound Findings.Archives of rheumatology
  • Not labelled yetCirc_0018814 promotes the osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis by regulating the miR-944/KLF4 axis.Journal of molecular histology
  • Not labelled yetDifficult-to-Manage Axial Spondyloarthritis: One Definition, Multiple Clinical Problems.The Journal of rheumatology